Letrozole
Luminal A Breast Cancer
University Hospital, AkershusSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Luminal A Breast Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ribociclib University Hospital, Akershus | Phase 2 | B |
Zoladex University Hospital, Akershus | Phase 2 | B |
Same molecule, other indications
Letrozole is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →